What is it about?
We showed that it is possible to predict survival in patients with chronic thromboembolic pulmonary hypertension using simple indices that are usually collected in the follow up of these patients.
Featured Image
Why is it important?
It is important because we had until now no validated risk assessment tool for patients with chronic thromboembolic pulmonary hypertension.
Read the Original
This page is a summary of: Risk assessment in medically treated Chronic Thromboembolic Pulmonary Hypertension patients, European Respiratory Journal, October 2018, European Respiratory Society (ERS),
DOI: 10.1183/13993003.00248-2018.
You can read the full text:
Contributors
The following have contributed to this page
